Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Phase 3
Recruiting
- Conditions
- GlioblastomaRecurrent GlioblastomaGBM
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- CarThera
- Target Recruit Count
- 560
- Registration Number
- NCT05902169
- Locations
- 🇺🇸
John Hopkins University, Baltimore, Maryland, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇦🇹Medizinische Universitaet Innsbruck, Innsbruck, Austria
Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- CarThera
- Target Recruit Count
- 38
- Registration Number
- NCT03744026
- Locations
- 🇫🇷
CHU, Angers, France
🇫🇷Hôpital de la Pitié-Salpêtrière, Paris, France
🇺🇸Northwestern University, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath